Skip to Content


In the US, Anagrelide (anagrelide systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Chronic Myelogenous Leukemia and Thrombocythemia.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiplatelet agent: Phosphodiesterase inhibitor

Chemical Name

6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one (WHO)

Foreign Names

  • Anagrelidum (Latin)
  • Anagrelid (German)
  • Anagrelide (French)
  • Anagrelida (Spanish)

Generic Names

Brand Names

  • Inaro
    Bioprofarma, Argentina
  • Thrombonorm
    Marcyrl, Egypt
  • Thromboreductin
    AOP, Bosnia & Herzegowina; AOP, Hungary; Dem IlaƧ, Turkey; Orpha-Devel, Poland; Orpha-Devel, Romania
  • Xagrid
    Shire, Spain; Shire, Poland
  • Agrelid
    Ariston, Argentina
  • Agrylin
    Mallinckrodt, Taiwan; Pratapa Nirmala/Fahrenheit, Indonesia; Shire, Australia; Shire, Canada; Shire, Hong Kong; Shire, Israel; Shire, Philippines; Shire, Thailand; Shire, United States; Tema Medical, South Africa
  • Anagrelide Orpha
    Aop Orphan Pharmaceuticals, Israel
  • Anagrid
    Rafa, Israel
  • PMS-Anagrelide
    Pharmascience, Canada
  • Sandoz Anagrelide
    Sandoz, Canada
  • Thromboreductin
    AOP Orphan, Bulgaria; AOP Orphan, Serbia; Combiphar/AOP Orphan, Indonesia; Hospira, Hong Kong; Hospira, Philippines; Key Oncologics, South Africa; Orpha Devel, Czech Republic; Orpha Devel, Latvia; OrPha Swiss, Switzerland; Orpha-Devel, Austria; Orpha-Devel, Lithuania; Providens, Croatia (Hrvatska)
  • Xagrid
    Farmagon, Norway; Opopharma, Switzerland; Shire, Belgium; Shire, Germany; Shire, Denmark; Shire, Finland; Shire, France; Shire, Greece; Shire, Iceland; Shire, Lithuania; Shire, Netherlands; Shire, Norway; Shire Human Genetic Therapies, Sweden; Shire Human Genetic Therapies AB, Portugal; Shire Italia, Italy; Shire Pharmaceuticals, United Kingdom; Shire Pharmaceuticals Ireland, Ireland


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.